glp-1 eye issues Drugs and Diabetic Disease: Ozempic, Semaglutide, and Retinopathy Risk Doctor Explains GLP 1 Blindness

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Tirzepatide, sold under the name Mounjaro, is among a handful of drugs with big buzz for their weight loss results, and approval for obesity could be a huge revenue source for Eli Lilly in the future.

A large retrospective cohort study of adult female breast cancer patients found that GLP-1 receptor agonist use was associated with better all-cause survival and recurrence-free survival in patients with obesity or type 2 diabetes

Conclusion: This review synthesizes current evidence on the safety and effectiveness of GLP-1RAs in weight management and potential cardiovascular protection

Walgreens launches a $49 per visit virtual weight management platform, offering self-pay patients access to GLP-1 prescriptions like Wegovy without monthly subscription fees.

Formulated for easy, consistent use, they fit seamlessly into your daily habits